News related to Nexavar (Sorafenib) and/or conditions it is approved for
Functional Genomics in Clear Cell Renal Cell Carcinoma
Source: Medscape Nephrology Headlines [2014.07.21]
Functional genomics has identified 31 potential therapeutic targets that contribute to clear cell renal cell carcinoma (ccRCC) proliferation, researchers report.
Reuters Health Information
OncoBriefs: Local Tx for mRCC, Cervical Ca Prevention (CME/CE)
Source: MedPageToday.com - medical news plus CME for physicians [2014.07.26]
(MedPage Today) -- More than 80% of patients with metastatic renal cell carcinoma remained alive without disease progression 3 years after image-guided local ablation of tumors, a retrospective study showed.
Enzyme may halt tumor growth in kidney cancer
Source: Urology / Nephrology News From Medical News Today [2014.07.22]
Researchers discover that FBP1 - an enzyme that controls metabolism - may halt tumor growth in clear cell renal cell carcinoma and is missing in tissue taken from its tumors.
31 genes discovered that are key to kidney cancer
Source: Urology / Nephrology News From Medical News Today [2014.07.03]
A genomic analysis of clear cell renal cell carcinoma (ccRCC), the most common form of kidney cancer, from 72 patients has uncovered 31 genes that are key to development, growth and spread of the...